Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Artemether-lumefantrine for uncomplicated Plasmodium falciparum malaria in Yemen
ACTRN12624000526572Phase 4Completed
- Sponsor
- Haiti Ministry of Public Health and Population
- Start
- Mar 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of artemether + lumefantrine in Malaria, sponsored by Haiti Ministry of Public Health and Population. Primary endpoint: Proportion of treatment failures. Started Mar 2023; status: completed.
02
Drugs
artemether + lumefantrine
03
Conditions
Malaria
Beyond the preview
Go deeper on ACTRN12624000526572.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12624000526572.